• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

模板递送方式的选择可减轻基因编辑对人造血干细胞的遗传毒性风险和不良影响。

Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells.

机构信息

San Rafaelle Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy; Vita-Salute San Raffaele University, Milan 20132, Italy.

San Rafaelle Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy.

出版信息

Cell Stem Cell. 2022 Oct 6;29(10):1428-1444.e9. doi: 10.1016/j.stem.2022.09.001.

DOI:10.1016/j.stem.2022.09.001
PMID:36206730
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9550218/
Abstract

Long-range gene editing by homology-directed repair (HDR) in hematopoietic stem/progenitor cells (HSPCs) often relies on viral transduction with recombinant adeno-associated viral vector (AAV) for template delivery. Here, we uncover unexpected load and prolonged persistence of AAV genomes and their fragments, which trigger sustained p53-mediated DNA damage response (DDR) upon recruiting the MRE11-RAD50-NBS1 (MRN) complex on the AAV inverted terminal repeats (ITRs). Accrual of viral DNA in cell-cycle-arrested HSPCs led to its frequent integration, predominantly in the form of transcriptionally competent ITRs, at nuclease on- and off-target sites. Optimized delivery of integrase-defective lentiviral vector (IDLV) induced lower DNA load and less persistent DDR, improving clonogenic capacity and editing efficiency in long-term repopulating HSPCs. Because insertions of viral DNA fragments are less frequent with IDLV, its choice for template delivery mitigates the adverse impact and genotoxic burden of HDR editing and should facilitate its clinical translation in HSPC gene therapy.

摘要

通过同源定向修复 (HDR) 在造血干细胞/祖细胞 (HSPC) 中进行长程基因编辑,通常依赖于使用重组腺相关病毒载体 (AAV) 进行病毒转导以递送模板。在这里,我们揭示了 AAV 基因组及其片段的意外负载和延长的持久性,它们在招募 AAV 反向末端重复序列 (ITR) 上的 MRE11-RAD50-NBS1 (MRN) 复合物后,引发持续的 p53 介导的 DNA 损伤反应 (DDR)。在细胞周期停滞的 HSPC 中积累的病毒 DNA 导致其频繁整合,主要是以转录有效的 ITR 形式,在核酸内切酶的靶内和靶外位点。整合酶缺陷型慢病毒载体 (IDLV) 的优化递送导致较低的 DNA 负载和较少的持续 DDR,从而提高了长期重编程 HSPC 的集落形成能力和编辑效率。由于 IDLV 中病毒 DNA 片段的插入较少,因此选择其作为模板递送可以减轻 HDR 编辑的不利影响和遗传毒性负担,并应有助于其在 HSPC 基因治疗中的临床转化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7212/9550218/80301a615b84/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7212/9550218/afdfd02ae285/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7212/9550218/ebcab2a90273/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7212/9550218/8b3256a8977b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7212/9550218/6386c1cdb027/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7212/9550218/d0568821a87a/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7212/9550218/480adda46a56/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7212/9550218/80301a615b84/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7212/9550218/afdfd02ae285/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7212/9550218/ebcab2a90273/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7212/9550218/8b3256a8977b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7212/9550218/6386c1cdb027/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7212/9550218/d0568821a87a/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7212/9550218/480adda46a56/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7212/9550218/80301a615b84/gr6.jpg

相似文献

1
Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells.模板递送方式的选择可减轻基因编辑对人造血干细胞的遗传毒性风险和不良影响。
Cell Stem Cell. 2022 Oct 6;29(10):1428-1444.e9. doi: 10.1016/j.stem.2022.09.001.
2
Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response.精确的基因编辑可保留短暂的 p53 介导的 DNA 损伤反应后造血干细胞的功能。
Cell Stem Cell. 2019 Apr 4;24(4):551-565.e8. doi: 10.1016/j.stem.2019.02.019. Epub 2019 Mar 21.
3
Answered and Unanswered Questions in Early-Stage Viral Vector Transduction Biology and Innate Primary Cell Toxicity for Gene Editing.早期病毒载体转导生物学和基因编辑固有原代细胞毒性的解答与未解问题
Front Immunol. 2021 May 28;12:660302. doi: 10.3389/fimmu.2021.660302. eCollection 2021.
4
The p53 challenge of hematopoietic stem cell gene editing.造血干细胞基因编辑中的p53挑战
Mol Ther Methods Clin Dev. 2023 Jun 12;30:83-89. doi: 10.1016/j.omtm.2023.06.003. eCollection 2023 Sep 14.
5
Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cells.脂质纳米颗粒可实现高效、无害的人类造血细胞体外基因编辑。
Blood. 2023 Aug 31;142(9):812-826. doi: 10.1182/blood.2022019333.
6
Homology-directed gene-editing approaches for hematopoietic stem and progenitor cell gene therapy.同源定向基因编辑方法在造血干细胞和祖细胞基因治疗中的应用。
Stem Cell Res Ther. 2021 Sep 9;12(1):500. doi: 10.1186/s13287-021-02565-6.
7
Recruitment of DNA Repair MRN Complex by Intrinsically Disordered Protein Domain Fused to Cas9 Improves Efficiency of CRISPR-Mediated Genome Editing.通过与 Cas9 融合的固有无序蛋白结构域募集 DNA 修复 MRN 复合物可提高 CRISPR 介导的基因组编辑效率。
Biomolecules. 2019 Oct 8;9(10):584. doi: 10.3390/biom9100584.
8
Integration-defective lentiviral vector mediates efficient gene editing through homology-directed repair in human embryonic stem cells.整合缺陷型慢病毒载体通过同源定向修复在人类胚胎干细胞中介导高效基因编辑。
Nucleic Acids Res. 2017 Mar 17;45(5):e29. doi: 10.1093/nar/gkw1057.
9
CRISPR-Cas9-AAV versus lentivector transduction for genome modification of X-linked severe combined immunodeficiency hematopoietic stem cells.CRISPR-Cas9-AAV 与慢病毒载体转导在 X 连锁严重联合免疫缺陷造血干细胞基因组修饰中的比较。
Front Immunol. 2023 Jan 4;13:1067417. doi: 10.3389/fimmu.2022.1067417. eCollection 2022.
10
Editing the Sickle Cell Disease Mutation in Human Hematopoietic Stem Cells: Comparison of Endonucleases and Homologous Donor Templates.编辑人类造血干细胞中的镰状细胞病突变:内切酶与同源供体模板的比较。
Mol Ther. 2019 Aug 7;27(8):1389-1406. doi: 10.1016/j.ymthe.2019.05.014. Epub 2019 May 24.

引用本文的文献

1
Lentiviral Vectors: From Wild-Type Viruses to Efficient Multi-Functional Delivery Vectors.慢病毒载体:从野生型病毒到高效多功能递送载体
Int J Mol Sci. 2025 Sep 1;26(17):8497. doi: 10.3390/ijms26178497.
2
Gene editing in hematopoietic stem cells by co-delivery of Cas9/sgRNA ribonucleoprotein and templates for homology-directed repair in 'all-in-one' lentivirus-derived nanoparticles.通过在“一体化”慢病毒衍生纳米颗粒中共递送Cas9/sgRNA核糖核蛋白和同源定向修复模板,对造血干细胞进行基因编辑。
Nucleic Acids Res. 2025 Aug 11;53(15). doi: 10.1093/nar/gkaf767.
3
Targeted gene editing and near-universal cDNA insertion of CYBA and CYBB as a treatment for chronic granulomatous disease.

本文引用的文献

1
Frequent aneuploidy in primary human T cells after CRISPR-Cas9 cleavage.CRISPR-Cas9 切割后原发性人 T 细胞中频繁的非整倍体。
Nat Biotechnol. 2022 Dec;40(12):1807-1813. doi: 10.1038/s41587-022-01377-0. Epub 2022 Jun 30.
2
Human and Insect Cell-Produced Recombinant Adeno-Associated Viruses Show Differences in Genome Heterogeneity.人源和昆虫细胞生产的重组腺相关病毒在基因组异质性方面存在差异。
Hum Gene Ther. 2022 Apr;33(7-8):371-388. doi: 10.1089/hum.2022.050.
3
Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler Syndrome.
靶向基因编辑以及CYBA和CYBB的近乎普遍的cDNA插入作为慢性肉芽肿病的一种治疗方法。
Nat Commun. 2025 Aug 12;16(1):7475. doi: 10.1038/s41467-025-62738-2.
4
Extracellular vesicle-mediated delivery of circp53 suppresses the progression of multiple cancers by activating the CypD/TRAP/HSP90 pathway.细胞外囊泡介导的环状p53递送通过激活CypD/TRAP/HSP90途径抑制多种癌症的进展。
Exp Mol Med. 2025 Aug 1. doi: 10.1038/s12276-025-01506-0.
5
Integrase-Deficient Lentiviral Vector as a Platform for Efficient CRISPR/Cas9-Mediated Gene Editing for Mucopolysaccharidosis IVA.整合酶缺陷型慢病毒载体作为黏多糖贮积症IVA的高效CRISPR/Cas9介导基因编辑平台
Int J Mol Sci. 2025 Jul 10;26(14):6616. doi: 10.3390/ijms26146616.
6
CRISPR-based therapeutic genome editing for inherited blood disorders.基于CRISPR的遗传性血液疾病治疗性基因组编辑
Nat Rev Drug Discov. 2025 Jul 14. doi: 10.1038/s41573-025-01236-y.
7
Dissecting the epigenetic regulation of the fetal hemoglobin genes to unravel a novel therapeutic approach for β-hemoglobinopathies.剖析胎儿血红蛋白基因的表观遗传调控,以揭示一种针对β-地中海贫血的新型治疗方法。
Nucleic Acids Res. 2025 Jul 8;53(13). doi: 10.1093/nar/gkaf637.
8
Have we really solved rAAV6 toxicity? A closer look at mannose-coupled rAAV6 vectors.我们真的解决了重组腺相关病毒6型(rAAV6)的毒性问题吗?深入研究甘露糖偶联的rAAV6载体。
Mol Ther Nucleic Acids. 2025 Jun 20;36(3):102603. doi: 10.1016/j.omtn.2025.102603. eCollection 2025 Sep 9.
9
Senescence and inflammation are unintended adverse consequences of CRISPR-Cas9/AAV6-mediated gene editing in hematopoietic stem cells.衰老和炎症是CRISPR-Cas9/AAV6介导的造血干细胞基因编辑产生的意外不良后果。
Cell Rep Med. 2025 Jun 17;6(6):102157. doi: 10.1016/j.xcrm.2025.102157. Epub 2025 Jun 3.
10
Fine-Tuning Homology-Directed Repair (HDR) for Precision Genome Editing: Current Strategies and Future Directions.用于精准基因组编辑的同源定向修复(HDR)微调:当前策略与未来方向
Int J Mol Sci. 2025 Apr 25;26(9):4067. doi: 10.3390/ijms26094067.
用于黏多糖贮积症I型的造血干细胞和祖细胞基因疗法
N Engl J Med. 2021 Nov 18;385(21):1929-1940. doi: 10.1056/NEJMoa2106596.
4
Toxicity after AAV delivery of RNAi expression constructs into nonhuman primate brain.腺相关病毒(AAV)载体递送 RNAi 表达构建体到非人灵长类动物脑内后的毒性。
Nat Med. 2021 Nov;27(11):1982-1989. doi: 10.1038/s41591-021-01522-3. Epub 2021 Oct 18.
5
Gene therapy community grapples with toxicity issues, as pipeline matures.随着基因治疗产品线的成熟,该领域正努力应对毒性问题。
Nat Rev Drug Discov. 2021 Nov;20(11):804-805. doi: 10.1038/d41573-021-00164-x.
6
AAV integration in human hepatocytes.AAV 在人肝细胞中的整合。
Mol Ther. 2021 Oct 6;29(10):2898-2909. doi: 10.1016/j.ymthe.2021.08.031. Epub 2021 Aug 28.
7
CRISPR-Cas9 globin editing can induce megabase-scale copy-neutral losses of heterozygosity in hematopoietic cells.CRISPR-Cas9 基因编辑可诱导造血细胞内中靶基因座的大片段拷贝数中性缺失。
Nat Commun. 2021 Aug 13;12(1):4922. doi: 10.1038/s41467-021-25190-6.
8
Retrieval of vector integration sites from cell-free DNA.从无细胞游离 DNA 中检索载体整合位点。
Nat Med. 2021 Aug;27(8):1458-1470. doi: 10.1038/s41591-021-01389-4. Epub 2021 Jun 17.
9
Development of β-globin gene correction in human hematopoietic stem cells as a potential durable treatment for sickle cell disease.β-珠蛋白基因校正在人类造血干细胞中的发展作为镰状细胞病的一种潜在持久治疗方法。
Sci Transl Med. 2021 Jun 16;13(598). doi: 10.1126/scitranslmed.abf2444.
10
BAR-Seq clonal tracking of gene-edited cells.BAR-Seq 对基因编辑细胞的克隆追踪。
Nat Protoc. 2021 Jun;16(6):2991-3025. doi: 10.1038/s41596-021-00529-x. Epub 2021 May 24.